Company news

Anbogen Therapeutics, Inc. news

Latest news releases, newest first.

Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion

August 23, 2026